Clinical trial
AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or…
NCT00325715 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00325715 |
|---|---|
| Title | AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Peptic Ulcer |
| Intervention type | Drug |
| Interventions | AGN 201904, esomeprazole |
| Enrollment | 150 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | May 15, 2006 |
| Last update posted | Jun 2, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: